Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Surface Oncology Announces Change to Location and Format of 2020 Annual Meeting of Stockholders

Read more ››
By: GlobenewsWire - 28 May 2020
Related companies:  Surface Oncology, Inc.

BioCryst to Present at Jefferies Virtual Healthcare Conference

Read more ››
By: GlobenewsWire - 28 May 2020
Related companies:  BioCryst Pharmaceuticals, Inc.

Phathom Pharmaceuticals to Present at Upcoming Investor Conferences

Read more ››
By: GlobenewsWire - 28 May 2020
Related companies:  Phathom Pharmaceuticals, Inc.

Amedisys to Present at the 2020 Jefferies Virtual Healthcare Conference

Read more ››
By: GlobenewsWire - 28 May 2020
Related companies:  Amedisys

MDxHealth Announces Results of Annual and Extraordinary General Shareholders' Meetings

Read more ››
By: GlobenewsWire - 28 May 2020
Related companies:  MDxHealth, Inc. | MDxHealth B.V. | MDxHealth S.A.

Mersana Therapeutics to Present at Jefferies Virtual Global Healthcare Conference

Read more ››
By: GlobenewsWire - 28 May 2020
Related companies:  Mersana Therapeutics, Inc.

Jushi Holdings Inc. to Report First Quarter 2020 Financial Results on or Before July 14, 2020

Read more ››
By: GlobenewsWire - 28 May 2020

LeMaitre Vascular to Present at the Jefferies Virtual Healthcare Conference

Read more ››
By: GlobenewsWire - 28 May 2020
Related companies:  LeMaitre Vascular, Inc.

AMCP Foundation P&T Competition Marks 20 Years; Winning Teams Develop Formulary Recommendations for Asthma Treatment

ALEXANDRIA, Va., May 28, 2020 /PRNewswire/ -- AMCP Foundation is pleased to announce that a team of student pharmacists from University of California, San Francisco School of Pharmacy took top honors in the 20th Annual National Student Pharmacy & Therapeutics (P&T) Competition.

Read more ››
By: PR Newswire Association LLC. - 28 May 2020

Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders

SAN DIEGO, May 28, 2020 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Tocagen Inc.

Viracta Therapeutics to Host Key Opinion Leader Call on the Treatment of EBV-Associated Lymphoma

SAN DIEGO, May 28, 2020 /PRNewswire/ -- Viracta Therapeutics, Inc. (the "Company"), a precision oncology company targeting virus-associated malignancies, today announced that it will host a key opinion leader (KOL) call discussing the treatment of Epstein-Barr virus (EBV)-associated lymphoma... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Viracta Therapeutics, Inc.

Ionis Pharmaceuticals to host 2020 virtual annual meeting of stockholders

CARLSBAD, Calif., May 28, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2020 virtual Annual Meeting of Stockholders and provide a general corporate update on Thursday, June 4, 2020. This event will be webcast live on the internet... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Ionis Pharmaceuticals, Inc.

Haemonetics Announces Sale Of U.S. Blood Donor Management Software Solution Assets To The GPI Group

BOSTON, May 28, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to sell certain blood donor management... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  HAEMONETICS CORPORATION

Patients Need to Choose Whether to Take Hydroxychloroquine, States the Association of American Physicians & Surgeons (AAPS)

TUCSON, Ariz., May 28, 2020 In what appears to be an escalating war against the use of hydroxychloroquine (HCQ) to protect against COVID-19, permitting over-the-counter (OTC) use under an emergency Executive Order may be the only way to allow patients to protect themselves, states the Association... Read more ››

By: PR Newswire Association LLC. - 28 May 2020

Landmark Opioid Agreement Provides Clear Path in Pursuing Litigation Settlements

DALLAS, May 28, 2020 /PRNewswire/ -- Members of the Plaintiffs Steering Committee in the Texas Opioid MDL are lauding a landmark agreement announced by the Texas Attorney General's office today that outlines how future legal settlements will be structured to assure that funds are fairly apportioned... Read more ››

By: PR Newswire Association LLC. - 28 May 2020

TerrAscend Reports First Quarter Net Sales of $34.8 Million and Adjusted EBITDA of $4.9 Million

-- Net sales increased 34% quarter-over-quarter and 139% year-over-year

Read more ››
By: PR Newswire Association LLC. - 28 May 2020

Amgen To Present At The Jefferies 2020 Virtual Healthcare Conference

THOUSAND OAKS, Calif., May 28, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Jefferies 2020 Virtual Healthcare Conference at 4:00 p.m. ET on Tuesday, June 2, 2020. David M. Reese, M.D., executive vice president of Research and Development at Amgen, will be leading the presentation.... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Amgen, Inc.

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer's Disease

SILVER SPRING, Md., May 28, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Tauvid (flortaucipir F18) for intravenous injection, the first drug used to help image a distinctive characteristic of Alzheimer's disease in the brain called tau pathology. Tauvid is a radioactive... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  U.S. Food and Drug Administration

Fusion Health Acquires Kalos, Inc.

WOODBRIDGE, N.J., May 28, 2020 /PRNewswire/ -- Fusion Health announced that it has completed its acquisition of 100% voting and non-voting shares of Kalos, Inc. Kalos, a leader in pharmacy management solutions, is located in Topeka, Kansas. The company is nationally recognized for its proven... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
Related companies:  Kalos Therapeutics, Inc.

Liminal BioSciences to present at Jefferies Virtual Healthcare Conference

LAVAL, QC, and CAMBRIDGE, United Kingdom, May 28, 2020 /CNW Telbec/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company today announced that Kenneth Galbraith, Chief Executive Officer at Liminal BioSciences... Read more ››

By: PR Newswire Association LLC. - 28 May 2020
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑